Last $2.59 USD
Change Today 0.00 / 0.00%
Volume 1.9M
SQNM On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul V. Maier M.B.A.

Chief Financial Officer, Sequenom Inc.
AgeTotal Calculated CompensationThis person is connected to 28 board members in 3 different organizations across 8 different industries.

See Board Relationships
65$1,003,543
As of Fiscal Year 2012

Background*

Mr. Paul V. Maier, M.B.A. has been the Chief Financial Officer of Sequenom Inc. since June 2010. Mr. Maier has been an Independent Financial Consultant since February 2007. He has over 20 years of experience as a senior executive in biotechnology and pharmaceutical companies. He served as Chief Financial Officer and Senior Vice President at Organon Pharmaceuticals USA, Inc. He served as a Consultant from October 2009 to November 10, 2009 and Interim Chief Financial Officer ...

Read Full Background

Corporate Headquarters*

3595 John Hopkins Court
San Diego, California 92121

United States

Phone: 858-202-9000
Fax: 858-202-9001

Board Members Memberships*

2000-2005
Former Director, Chairman of Audit Committee and Member of Nominating and Corporate Governance Committee
2007-Present
Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Governance Committee
2008-2013
Former Director, Chairman of Audit Committee and Chairman of Compensation Committee
2008-Present
Director, Chairman of Audit Committee, Member of Special Committee and Member of Finance & Transactions Committee
2012-Present
Director, Chairman of Audit Committee and Member of Corporate Governance/Nominating Committee

Education*

MBA
Harvard University
BS
Pennsylvania State University

Other Affiliations*

Annual Compensation*

Salary$340,673
Total Annual Compensation$340,673

Stock Options*

All Other Compensation$5,780
Exercisable Options56,563
Unexercisable Options139,937
Total Number of Options196,500

Total Compensation*

Total Annual Cash Compensation$484,494
Total Short Term Compensation$340,673
Other Long Term Compensation$5,780
Total Calculated Compensation$1,003,543
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SQNM:US $2.59 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Hany Massarany Chief Executive Officer, President and Director
GenMark Diagnostics, Inc.
$450.0K
Patrick J. Balthrop Sr.Chief Executive Officer, President, Director, Member of Executive Committee and Member of Strategy & Development Committee
Luminex Corporation
$700.0K
Michael K. McGarrity Chief Executive Officer, President and Director
Nanosphere, Inc.
$330.0K
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
$384.2K
Michael W. Hunkapiller Ph.D.Executive Chairman, Chief Executive Officer, President and Member of Compensation Committee
Pacific Biosciences of California, Inc.
$1.00
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEQUENOM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.